ImageneBio (IMA) News Today $8.15 +0.45 (+5.84%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IMA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period ImageneBio (IMA) & Its Competitors Head to Head ReviewSeptember 28 at 3:19 AM | americanbankingnews.comWall Street Zen Upgrades ImageneBio (NASDAQ:IMA) to HoldSeptember 27 at 2:19 AM | americanbankingnews.comImageneBio files to sell 2.51M shares of common stock for holdersSeptember 9, 2025 | msn.comImageneBio Inc trading halted, volatility trading pauseSeptember 4, 2025 | msn.comImageneBio (NASDAQ:IMA) Shares Down 1.3% - Should You Sell?August 31, 2025 | marketbeat.comIkena Oncology (IMA) Projected to Post Quarterly Earnings on ThursdayAugust 7, 2025 | marketbeat.comQ3 EPS Estimates for Ikena Oncology Lifted by William BlairAugust 4, 2025 | marketbeat.comWilliam Blair Estimates Ikena Oncology FY2029 EarningsAugust 2, 2025 | marketbeat.comImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 1, 2025 | globenewswire.comIkena Oncology, Inc. (NASDAQ:IMA) Director David P. Bonita Buys 83,611 SharesJuly 31, 2025 | marketbeat.comInsider Buying: Ikena Oncology, Inc. (NASDAQ:IMA) Director Acquires 267,556 Shares of StockJuly 31, 2025 | marketbeat.comIkena Oncology, Inc. (NASDAQ:IMA) Director Purchases $2,499,968.90 in StockJuly 31, 2025 | insidertrades.comIkena Oncology (NASDAQ:IMA) Stock Price Down 7% - What's Next?July 30, 2025 | marketbeat.comIkena Oncology (NASDAQ:IKNA) Issues Earnings ResultsJuly 27, 2025 | marketbeat.comIkena Oncology (NASDAQ:IKNA) Given New $23.00 Price Target at WedbushJuly 26, 2025 | marketbeat.comIkena Oncology Inc trading halted, news pendingJuly 26, 2025 | msn.comInmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 MillionJuly 25, 2025 | globenewswire.comIkena Oncology shares climb as Kristin Yarema named CEO of soon-to-merge ImageneBioJuly 24, 2025 | msn.comIkena Oncology stock rises after naming Kristin Yarema as CEO of combined companyJuly 24, 2025 | investing.comIkena Oncology and Inmagene Biopharmaceuticals Announce Kristin Yarema, Ph.D., as Chief Executive Officer of Merged CompanyJuly 23, 2025 | globenewswire.comIkena Oncology, Inc.: Ikena Oncology Announces Stockholder Approval of Merger with Inmagene BiopharmaceuticalsJuly 16, 2025 | finanznachrichten.deIkena Oncology Announces Stockholder Approval of Merger with Inmagene BiopharmaceuticalsJuly 15, 2025 | globenewswire.comIkena Oncology, Inc.: Ikena Oncology Announces ISS and Glass Lewis Recommend Stockholders Vote "FOR" Proposed Merger with Inmagene BiopharmaceuticalsJuly 15, 2025 | finanznachrichten.deIkena Oncology Announces ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Merger with Inmagene BiopharmaceuticalsJuly 11, 2025 | globenewswire.comPeapod Lane Capital LLC Trims Stock Holdings in Ikena Oncology, Inc. (NASDAQ:IKNA)July 10, 2025 | marketbeat.comIkena Oncology (NASDAQ:IKNA) Stock Price Up 1.5% - Here's WhyJuly 9, 2025 | marketbeat.comIkena Oncology, Inc. (NASDAQ:IKNA) Sees Significant Decrease in Short InterestJune 17, 2025 | marketbeat.comIkena Oncology Reports Q1 Loss Amid Merger PlansMay 27, 2025 | tipranks.comIkena Oncology (NASDAQ:IKNA) Releases Earnings Results, Beats Expectations By $0.03 EPSMay 14, 2025 | marketbeat.comBrokers Set Expectations for Ikena Oncology Q1 EarningsMay 13, 2025 | marketbeat.comIkena Oncology (IKNA) Expected to Announce Earnings on MondayMay 7, 2025 | marketbeat.comBVF Inc. IL Sells 762,600 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA)May 6, 2025 | marketbeat.comIkena Oncology, Inc. (NASDAQ:IKNA) Short Interest UpdateApril 21, 2025 | marketbeat.com2,008,338 Shares in Ikena Oncology, Inc. (NASDAQ:IKNA) Purchased by Gilead Sciences Inc.April 20, 2025 | marketbeat.comIkena Oncology, Inc. (NASDAQ:IKNA) Stake Boosted by BML Capital Management LLCMarch 8, 2025 | marketbeat.comIkena Oncology (NASDAQ:IKNA) Releases Earnings Results, Beats Estimates By $0.05 EPSMarch 7, 2025 | marketbeat.comIkena Oncology: Investor Caution as Dividend Payments Remain UnlikelyMarch 7, 2025 | tipranks.comIkena Oncology, Inc. (NASDAQ:IKNA) Short Interest Up 34.1% in FebruaryMarch 4, 2025 | marketbeat.comIkena Oncology (IKNA) to Release Earnings on TuesdayMarch 4, 2025 | marketbeat.comIkena Oncology, Inc. (NASDAQ:IKNA) Short Interest Down 11.8% in JanuaryFebruary 19, 2025 | marketbeat.comDiscovering February 2025's Promising Penny Stocks On US ExchangesFebruary 14, 2025 | finance.yahoo.comPeapod Lane Capital LLC Makes New $833,000 Investment in Ikena Oncology, Inc. (NASDAQ:IKNA)February 13, 2025 | marketbeat.comIkena Oncology (NASDAQ:IKNA) Trading Down 0.7% - Here's WhyFebruary 6, 2025 | marketbeat.comWilliam Blair Reaffirms Their Buy Rating on Ikena Oncology (IKNA)December 29, 2024 | markets.businessinsider.comiKena Oncology, Inmagene enter definitive merger agreement, private placementDecember 24, 2024 | markets.businessinsider.comIkena Oncology's (IKNA) "Neutral" Rating Reaffirmed at WedbushDecember 23, 2024 | marketbeat.comIkena Oncology Shares Rise After Merger Announcement With Inmagene BiopharmaceuticalsDecember 23, 2024 | marketwatch.comIkena Oncology, Inmagene Biopharmaceuticals to MergeDecember 23, 2024 | marketwatch.comIkena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private PlacementDecember 23, 2024 | globenewswire.comIkena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private PlacementDecember 23, 2024 | globenewswire.com Get ImageneBio News Delivered to You Automatically Sign up to receive the latest news and ratings for IMA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMA Media Mentions By Week IMA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMA News Sentiment▼0.220.87▲Average Medical News Sentiment IMA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMA Articles This Week▼41▲IMA Articles Average Week Get the Latest News and Ratings for IMA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for ImageneBio and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ONCY News Today CGEN News Today HURA News Today EXOZ News Today KALA News Today BMEA News Today TIL News Today SKYE News Today STTK News Today FATE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMA) was last updated on 9/30/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuy this stock tomorrowFamed futurist Eric Fry just unveiled his “Sell This, Buy That” strategy — including 7 free trade ideas like a...InvestorPlace | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImageneBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImageneBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
